Muscular weakness: FDA reporting patterns
112,135 FDA FAERS reports mention Muscular weakness. 76,376 reports have a serious outcome flag.
Medicines named as suspect
- Adalimumab: 5,034 reports
- Natalizumab: 4,418 reports
- Atorvastatin: 4,330 reports
- Etanercept: 4,074 reports
- Interferon Beta-1a: 3,244 reports
- Methotrexate: 3,240 reports
- Rituximab: 3,125 reports
- Simvastatin: 2,727 reports
- Prednisone: 2,707 reports
- Dalfampridine: 2,201 reports
- Acetaminophen: 2,181 reports
- Fingolimod: 2,170 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.